Table 4.
Demographics, patient-reported symptoms, physical function, and cartilage lesions between a subgroup of subjects with compositional abnormalities and remaining controls.
| Subgroup (n=16) |
Control (n=39) |
p value | |
|---|---|---|---|
| Demographics | |||
| Sex, n† | 9 males, 7 females | 19 males, 20 females | 0.612 |
| Age, y | 42.7 ± 13.6 | 40.7 ± 11.44 | 0.588 |
| BMI, kg/m2 | 25.2 ± 3.1 | 23.5 ± 3.0 | 0.068 |
| KL grade (0-4) | 8 KL=0, 8 KL=1 | 18 KL=0, 21 KL=1 | 0.795 |
| HOOS, % | |||
| Pain | 96.2 ± 7.6 | 92.8 ± 14.4 | 0.379 |
| Symptoms | 94.6 ± 7.6 | 91.1 ± 13.6 | 0.332 |
| Daily activity | 95.5 ± 8.8 | 96.1 ± 12.0 | 0.854 |
| Sports | 94.5 ± 9.6 | 93.7 ± 13.9 | 0.840 |
| Quality of life | 92.1 ± 14.3 | 87.8 ± 18.2 | 0.404 |
| Physical Function | |||
| TUG, s | 6.5 ± 1.1 | 5.7 ± 0.7 | 0.003 |
| 6MWT, m | 626.4 ± 93.7 | 644.0 ± 88.2 | 0.527 |
| Subjects with Lesions, n (%)† (SHOMRI ≥ 1) | |||
| Acetabular | |||
| Superolateral | 3 (18.7) | 5 (12.8) | 0.571 |
| Superomedial | 5 (31.2) | 5 (12.8) | 0.274 |
| Anterior | 4 (25.0) | 6 (15.3) | 0.267 |
| Posterior | 0 (0.0) | 2 (5.1) | 0.356 |
| Total | 7 (43.7) | 12 (30.7) | 0.658 |
| Femoral | |||
| Lateral | 7 (43.7) | 4 (10.2) | 0.009 |
| Superolateral | 4 (25.0) | 9 (23.0) | 0.771 |
| Superomedial | 3 (18.7) | 9 (23.0) | 0.878 |
| Inferomedial | 4 (25.0) | 2 (5.1) | 0.032 |
| Anterior | 2 (12.5) | 6 (15.3) | 0.783 |
| Posterior | 1 (6.2) | 4 (10.2) | 0.433 |
| Total | 8 (50.0) | 20 (51.2) | 0.448 |
Data presented as mean ± SD. Abbreviations: 6MWT, six-minute walk test; BMI, body mass index; KL, Kellgren-Lawrence; HOOS, Hip injury and Osteoarthritis Outcome Scores; SHOMRI, Scoring Hip OA with MR imaging; TUG, Timed Up and Go.
†
Indicates chi-square analysis.